![Li Hua Zheng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Hua Zheng
Founder at AnHeart Therapeutics (Hangzhou) Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bing Yan | M | - |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | 6 years |
Jun Yuan Wang | M | 51 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | 6 years |
Peter Traber | M | 69 |
Baylor College of Medicine
| 21 years |
John Vierling | M | 78 |
Baylor College of Medicine
| 19 years |
Raymond Sawaya | M | - |
Baylor College of Medicine
| 19 years |
Xiao Hang Tong | M | 41 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
Juan Vera | M | 44 |
Baylor College of Medicine
| 20 years |
Zheng Wei Zhu | M | 50 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
Xu Wei | M | - |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Brett C. Sweet | M | - |
Baylor College of Medicine
| 4 years |
Stanley H. Appel | M | - |
Baylor College of Medicine
| 27 years |
Norman Michael Greenberg | M | 64 |
Baylor College of Medicine
| 5 years |
Jannapureddy Madhu | M | - |
Baylor College of Medicine
| 4 years |
Shuo Dong | M | 60 |
Baylor College of Medicine
| 11 years |
Kyu Hyung Ha | M | - |
Fordham University School of Law
| 3 years |
Ariel Choi | F | - |
Fordham University School of Law
| 3 years |
Christopher Santopolo | M | - |
Fordham University School of Law
| 3 years |
Faris Elrabie | M | - |
Fordham University School of Law
| 3 years |
An Kang Li | M | 47 |
Baylor College of Medicine
| 3 years |
Nicole Conner | F | - |
Fordham University School of Law
| 3 years |
Ada Ester Giovanna Villa | F | 47 |
Fordham University School of Law
| 3 years |
Qing Yang | F | 41 |
Fordham University School of Law
| 3 years |
Aaron Foster | M | 52 |
Baylor College of Medicine
| 8 years |
Ronald A. Morton | M | 65 |
Baylor College of Medicine
| 9 years |
Benjamin Magleby | M | - |
Fordham University School of Law
| 3 years |
Annie Dean | F | - |
Fordham University School of Law
| 3 years |
Scott Birnbaum | M | - |
Fordham University School of Law
| 3 years |
Emily Yudofsky | F | - |
Baylor College of Medicine
| 1 years |
Charmaine Chan | M | - |
Baylor College of Medicine
| - |
Wayne Riley | M | 64 |
Baylor College of Medicine
| 6 years |
Dianne K. McKeever | F | 46 |
Fordham University School of Law
| 4 years |
Ralph D. Feigin | M | - |
Baylor College of Medicine
| 7 years |
Donna R. Rill | F | 70 |
Baylor College of Medicine
| 6 years |
Charles M. Strother | M | 84 |
Baylor College of Medicine
| 3 years |
Anup Parikh | M | - |
Baylor College of Medicine
| 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 30 | 85.71% |
China | 5 | 14.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Li Hua Zheng
- Personal Network